Insider Buying and Selling - RLMD

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
08/28/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	55,976 @ $0.74	$41,422.24	1,000,000	(5.93%)	Direct
08/27/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	129,455 @ $0.67	$86,734.85	944,024	(15.89%)	Direct
08/26/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	80,545 @ $0.62	$49,937.90	814,569	(10.97%)	Direct
05/20/2025	05/20/2025	Shenouda Maged Chief Financial Officer CFO	Buy	60,000 @ $0.52	$31,422.00	288,335	(26.28%)	Direct
05/20/2025	05/20/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	147,686 @ $0.56	$82,246.33	734,024	(25.19%)	Direct
05/19/2025	05/20/2025	Shenouda Maged Chief Financial Officer CFO	Buy	90,000 @ $0.49	$43,686.00	228,335	(65.06%)	Direct
05/19/2025	05/20/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	30,000 @ $0.50	$14,994.00	586,338	(5.39%)	Direct
05/16/2025	05/20/2025	Ence Chuck CA and CO Officer	Buy	228,961 @ $0.45	$103,330.10	267,931	(587.53%)	Direct
05/16/2025	05/20/2025	Kelly Paul Edward Chief Operating Officer Officer Director	Buy	200,000 @ $0.43	$86,060.00	412,295	(94.21%)	Direct
05/16/2025	05/20/2025	Shenouda Maged Chief Financial Officer CFO	Buy	50,000 @ $0.44	$22,100.00	138,335	(56.60%)	Direct
05/16/2025	05/20/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	172,314 @ $0.45	$77,472.37	556,338	(44.87%)	Direct

Relmada Therapeutics, Inc. - RLMD